Table 1 Summary of patients characteristics at treatment start

Site

Oral Cavity

Nasopharynx

Oropharynx

Hypopharynx

Larynx

Nasal Cavity and Paranasal Sinuses

Other

7

3

16

1

10

6

2

Histology

Squamous cell carcinoma

Differentiated carcinoma

Undifferentiated carcinoma

Adenoidocistic carcinoma

Estesioneuroblastoma

Sarcomas

34

1

2

3

3

2

Sex

Males

Females

28

17

Age

Performance Status

Median [range]

PS 0

PS 1

PS 2

65 [28, 96] y.o.

28

11

6

Diagnostic imaging

PET

RM

6

45

Stage

II

III

IV

4

8

33

Chemotherapy

No ChT

CDDP

Cetuximab

10

16

19

Radiation Dose Prescription

Group A: 69.96/54.45Gy in 33 fractions

Group B: 66.0/54.45 Gy in 33 fractions

Group C: 55Gy in 25 fractions

36

3

6